Pfizer’s tofacitinib gains usage traction based on data from Brazilian hospitalized patients

USA – Pfizer Inc. and The Academic Research Organization (ARO) from the Hospital Israelita Albert Einstein announced that the findings from the STOP-COVID study came out positive. The New England Journal of Medicine published positive findings from the study evaluating the efficacy and safety of oral Janus kinase (JAK) inhibitor tofacitinib in 289 hospitalized adult patients with COVID-19 pneumonia who were not on ventilation. Tofacitinib is a type of drug known as a Janus kinase (JAK) inhibitor that works by blocking the action of Janus kinase enzymes, which are involved…

Read More

CureVac’s vaccine proves to have a 47% efficacy rating after its preliminary results

EUROPE – The German company CureVac provided disappointing preliminary results from a clinical trial of its COVID-19 vaccine, dimming hopes that it could help fill the world’s current greatest need. The trial, which included 40,000 volunteers in Latin America and Europe, estimated that CureVac’s mRNA vaccine had an efficacy of just 47 percent, among the lowest reported so far from any COVID-19 vaccine maker. Results released were based on data from 135 volunteers who got sick with COVID-19 as an independent panel compared the number of sick people who had…

Read More

Serum Institute to introduce Novavax’s vaccine in India by September

INDIA – The Indian government through the Serum Institute of India (SII) is planning to introduce an Indian version of Covavax originally formulated by a US based biotech company, Novavax Inc. Clinical trials are underway in India and the vaccine is likely to hit the market under the name Covavax by September this year though clinical trials on children are expected to kick-off from July. The vaccine is among the first to have undergone phase 3 clinical trials at a time when new Covid-19 variants of concern such as the…

Read More

The International Olympics Committee sets up vaccination hubs in Rwanda and Qatar

QATAR AND RWANDA – Qatar and Rwanda established vaccination hubs for pre-games vaccination of Olympic and Paralympic Games participants in collaboration with the IOC, National Olympic Committees (NOC), government authorities and Pfizer. These two vaccination hubs allow Games participants who will be unable to be vaccinated in their home countries in advance of travelling to Japan for the Olympic and Paralympic Games Tokyo 2020 to get inoculated. The two hubs will both offer the Pfizer-BioNTech vaccine, in line with the IOC announcement on 6 May 2021 of the signing of…

Read More

CDC study shows mRNA COVID-19 vaccines are 94% effective in health care personnel

U.S – New C0VID-19 vaccines effectiveness study conducted by CDC shows that mRNA vaccines by Pfizer-Biotech and Moderna reduce ri According to the study, the FDA approved vaccines reduced the risk of contracting SARS-CoV-2 virus by 94% among health care workers who were fully vaccinated. This study is the largest one to date, covering a sample size distribution of 500,000 health care personnel across 25 U.S. states, provides concrete evidence that C0VID-19 vaccines are performing as expected in the real world. Compared to the earlier study by CDC  on health…

Read More

European Union to spend US$1.2b in constructing vaccine factories in Africa

AFRICA – The European Union is planning to invest US$1.2 billion to facilitate construction of vaccine factories in Africa, Commission President Ursula von der Leyen has said. The president added that this will help the continent, where vaccination against COVID-19 has barely begun in many countries, to catch up. The bloc’s head made the pledges in Rome at a health summit of the G20, the world’s major economies. “Preventing future health emergencies means strengthening capacities throughout the world. Today, Africa imports 99% of its vaccines. This has to change. Therefore,…

Read More